Experiment 394619
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Ginkgo biloba (GINKGOACEAE) |
| Citation | GARG,RK: NAG,D: AGRAWAL,A:. (1995). A DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF GINKGO BILOBA EXTRACT IN ACUTE CEREBRAL ISCHAEMIA.. 43(11) |
| Amount utilized | |
| Compound isolated | |
| Disease | A DOUBLE BLIND PLACEBO CONTROLLED TRIAL WAS CONDUCTED IN 55 PATIENTS OF ACUTE ISCHAEMIC STROKE. TWENTY ONE AND TWENTY SIX PATIENTS WERE RANDOMLY ALLOTTED IN GROUP A AND GROUP B RESPECTIVELY. IN GROUP A, THE PATIENTS RECEIVED 40 MG GINKGO BILOBA EXTRACT AT 6 HOURLY INTRERVALS ALONG WITH ROUTINE MANAGEMENT. THE PLACEBO TABLETS WERE DISPENSED IN THE TABLET FORM OF SAME SIZE, SHAPE AND COLOUR AND WERE GIVEN IN THE SAME WAY. AFTER THE PATIENTS WERE SUBJECTED TO COMPUTERIZED TOMOGRAPHIC (CT) SCAN TO CONFIRM ACUTE ISCHAEMIC INFARCTION, THEY WERE ASSESSED ON MATHEW'S SCALE AND REASSESSED, AT 2 WEEKS AND 4 WEEKS OF DRUG/PLACEBO ADIMINSTRATIOH. BOTH GROUPS SHOWED SIGNIFICANT IMPROVEMENT IN MATHEW'S SCALE SCORE AFTER 2 WEEKS AND 4 WEEKS. THE DIFFERENCE IN DEGREE OF CHANGE WAS NEGLIGIBLE (P>0.05) IN EITHER GROUP. ESTIMATION OF RELATIVE CHANGES OF NEUROLOGICAL DEFICIT BASED ON BASELINE VALUES ALSO SHOWED NEGLIGIBLE (P>0.05) DIFFERENCE. |
| Dose amount | 160.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | ETOH(100%)EXT |
| Gender | GIVEN TO BOTH SEXES |